TickerFacts.

A business in context

WVE research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-22 · 8029 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. DEF 14A · Proxy statement

    Report date 2026-11-12 · 0001193125-26-421806

  2. 4 · Ownership change

    Report date 2026-10-05 · 0001231919-26-001433

  3. 4 · Ownership change

    Report date 2026-10-05 · 0001193125-26-417237

  4. 4 · Ownership change

    Report date 2026-10-05 · 0001193125-26-417236

  5. 4 · Ownership change

    Report date 2026-10-05 · 0001193125-26-417235

  6. 4 · Ownership change

    Report date 2026-10-05 · 0001193125-26-417234

  7. 4 · Ownership change

    Report date 2026-10-05 · 0001193125-26-417233

  8. 4 · Ownership change

    Report date 2026-10-05 · 0001193125-26-417232

  9. 4 · Ownership change

    Report date 2026-10-05 · 0001193125-26-417231

  10. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001193125-26-324949

  11. 8-K · Current report

    Report date 2026-07-30 · 0001193125-26-324917 · Items 2.02,7.01,9.01

  12. 8-K · Current report

    Report date 2026-06-22 · 0001193125-26-284002 · Items 5.07

  13. 8-K · Current report

    Report date 2026-05-18 · 0001193125-26-229076 · Items 7.01,8.01,9.01

  14. DEF 14A · Proxy statement

    Report date 2026-06-22 · 0001193125-26-211828

  15. 10-K/A · Annual report

    Report date 2025-12-31 · 0001193125-26-197330

  16. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001193125-26-183587

  17. 8-K · Current report

    Report date 2026-04-28 · 0001193125-26-183563 · Items 2.02,7.01,9.01

  18. 8-K · Current report

    Report date 2026-04-21 · 0001193125-26-167070 · Items 8.01,9.01

  19. 8-K · Current report

    Report date 2026-04-15 · 0001193125-26-157003 · Items 1.01,8.01,9.01

  20. 8-K · Current report

    Report date 2026-03-26 · 0001193125-26-125092 · Items 7.01,8.01,9.01

  21. 10-K · Annual report

    Report date 2025-12-31 · 0001193125-26-073472

  22. 8-K · Current report

    Report date 2026-02-26 · 0001193125-26-073437 · Items 2.02,7.01,9.01

  23. 8-K · Current report

    Report date 2026-02-02 · 0001193125-26-032698 · Items 8.01,9.01

  24. 8-K · Current report

    Report date 2026-01-12 · 0001193125-26-009784 · Items 2.02,7.01,9.01

  25. 8-K · Current report

    Report date 2025-12-09 · 0001193125-25-314746 · Items 1.01,7.01,8.01,9.01

  26. 8-K · Current report

    Report date 2025-12-08 · 0001193125-25-310595 · Items 7.01,8.01,9.01

  27. 8-K · Current report

    Report date 2025-11-17 · 0001193125-25-283929 · Items 7.01,9.01

  28. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001193125-25-273288

  29. 8-K · Current report

    Report date 2025-11-10 · 0001193125-25-273278 · Items 2.02,9.01

  30. 8-K/A · Current report

    Report date 2025-10-29 · 0001193125-25-257298 · Items 7.01,8.01,9.01

  31. 8-K · Current report

    Report date 2025-10-29 · 0001193125-25-256682 · Items 7.01,8.01,9.01

  32. 8-K · Current report

    Report date 2025-09-24 · 0001193125-25-214176 · Items 7.01,9.01

  33. 8-K · Current report

    Report date 2025-09-03 · 0001193125-25-194511 · Items 7.01,8.01,9.01

  34. 8-K · Current report

    Report date 2025-08-05 · 0001193125-25-178083 · Items 5.02,5.07,9.01

  35. 8-K · Current report

    Report date 2025-08-05 · 0001193125-25-173053 · Items 7.01,9.01

  36. 8-K · Current report

    Report date 2025-07-30 · 0001193125-25-168644 · Items 2.02,9.01

  37. 10-Q · Quarterly report

    Report date 2025-06-30 · 0000950170-25-099884

  38. DEF 14A · Proxy statement

    Report date 2025-08-05 · 0001193125-25-144678

  39. 8-K · Current report

    Report date 2025-05-08 · 0001193125-25-115489 · Items 2.02,7.01,9.01

  40. 10-Q · Quarterly report

    Report date 2025-03-31 · 0000950170-25-066404

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-15 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 4 transaction rows4SGrant / award: 0 transaction rows0AExercise / conversion: 2 transaction rows2MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

6 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-08-12
2026-08-13
Rawcliffe AdrianS · Sale
Disposed
Common Stock12700.05.29
2026-08-11
2026-08-13
Wagner Heidi LS · Sale
Disposed
Common Stock7000.06.01
2026-08-11
2026-08-13
Wagner Heidi LM · Exercise / conversion
Acquired
Common Stock7000.05.97
2026-08-11
2026-08-13
Wagner Heidi LM · Exercise / conversion
Disposed
Stock Option (right to buy)
Derivative security
7000.00.0
2026-08-11
2026-08-13
TAKANASHI KENS · Sale
Disposed
Common Stock3864.06.01
2026-08-11
2026-08-13
Tan Aik NaS · Sale
Disposed
Common Stock432.06.01

Identity & relationships

Wikidata structured data · retrieved 2026-10-15 · 1663 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001631574Wave Life Sciences, Inc.

No parent relationship is available in this import; this is not proof of independence.

Legal Entity Identifier
54930070006GPKFYZ813
GLEIF legal name
WAVE LIFE SCIENCES LTD.
Entity / LEI registration status
ACTIVE / LAPSED
Reference data updated
2026-03-09T14:34:10Z

direct-parent: no parent LEI supplied

ultimate-parent: no parent LEI supplied

GLEIF legal entity reference data · retrieved 2026-10-15 · 1199 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • Wave Life Sciences · alias · wikidata
  • Wave Life Sciences Ltd. · alias · wikidata
  • Wave Life Sciences UK Limited · alias · wikidata
  • Wave Life Sciences USA · alias · wikidata
  • Wave Life Sciences Ltd. · former SEC name · 2017-07-06 to 2026-07-30
  • Wave Life Sciences LTD. · former SEC name · 2017-07-06 to 2026-07-30
  • WAVE Life Sciences Ltd. · former SEC name · 2017-07-06 to 2026-07-30
  • Wave Life Sciences Pte Ltd · former SEC name · 2015-02-02 to 2015-11-02
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$108.30M$116.33M
2023-12-31$113.31M$125.29M
2022-12-31$3.65M$4.20M
2021-12-31$40.96M$50.93M
2020-12-31$20.08M$26.14M
2019-12-31$15.98M$21.06M
2018-12-31$14.41M$19.34M
2017-12-31$3.89M$5.35M

Bureau of Labor Statistics · retrieved 2026-10-22 · 9 selected series; gaps remain missing

Explore the CPI history ↗